In a human ovarian cancer model, H3K27me3 mediated by EZH2 at their promoter regions represses the tumor production of Th1-associated chemokines like CXCL10, which influences tumor progression by mediating recruitment of effector T cells to TME 115. Here, EZH2 is linked to neoplasm.